ES2081981T3 - Determinacion de los factores que afectan la regulacion y/o replicacion de genes. - Google Patents

Determinacion de los factores que afectan la regulacion y/o replicacion de genes.

Info

Publication number
ES2081981T3
ES2081981T3 ES90906232T ES90906232T ES2081981T3 ES 2081981 T3 ES2081981 T3 ES 2081981T3 ES 90906232 T ES90906232 T ES 90906232T ES 90906232 T ES90906232 T ES 90906232T ES 2081981 T3 ES2081981 T3 ES 2081981T3
Authority
ES
Spain
Prior art keywords
cell
reproduction
factor
recombinant dna
plasmid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90906232T
Other languages
English (en)
Inventor
Matti Karp
Matti Korpela
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bio Orbit Oy
Original Assignee
Bio Orbit Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Orbit Oy filed Critical Bio Orbit Oy
Application granted granted Critical
Publication of ES2081981T3 publication Critical patent/ES2081981T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

LA INVENCION SE REFIERE A UN METODO PARA DETERMINAR UN FACTOR QUE AFECTA A UNA CELULA, QUE AFECTA DIRECTA O INDIRECTAMENTE AL ADN, ARN Y/O PROTEINAS DE LA CELULA O SU SISTEMA DE SINTESIS EN QUE SE TRANSFIERE PLASMIDO DE ADN RECOMBINANTE A LA CELULA, Y EL PUNTO INICIAL O PUNTOS DEL SISTEMA DE REPRODUCCION RESPONSABLE DE SU REPRODUCCION SON SOMETIDOS A UN PROMOTOR AJUSTABLE, QUE SE PUEDE CONTROLAR BIEN MEDIANTE REALIMENTACION POSITIVA O NEGATIVA; LA CELULA QUE CONTIENE EL PLASMIDO DE ADN RECOMBINANTE SE PONE EN CONTACTO CON EL FACTOR DE AFECTACION; SE DEJA QUE EL FACTOR DE AFECTACION AFECTE A LA CELULA QUE CONTIENE EL PLASMIDO DE ADN RECOMBINANTE DURANTE UN PERIODO DE TIEMPO ADECUADO TRAS EL CUAL SE ACTIVA EL PROMOTOR QUE AJUSTA EL PUNTO DE INICIO DEL SISTEMA DE REPRODUCCION RESPONSABLE DE LA REPRODUCCION DEL PLASMIDO DE ADN RECOMBINANTE, CON LO QUE EL NUMERO DE COPIAS DEL PLASMIDO EMPIEZA A CRECER EN LA CELULA A MENOS QUE EL FACTOR DE AFECTACION NO HAY INHIBIDO LA REPRODUCCION DEL PLASMIDO;EL AUMENTO DEL NUMERO DE COPIAS DEL PLASMIDO DE ADN RECOMBINANTE EN LA CELULA SE DETERMINA DIRECTA O INDIRECTAMENTE.
ES90906232T 1989-04-20 1990-04-20 Determinacion de los factores que afectan la regulacion y/o replicacion de genes. Expired - Lifetime ES2081981T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI891899A FI88309C (fi) 1989-04-20 1989-04-20 Ny biotest

Publications (1)

Publication Number Publication Date
ES2081981T3 true ES2081981T3 (es) 1996-03-16

Family

ID=8528282

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90906232T Expired - Lifetime ES2081981T3 (es) 1989-04-20 1990-04-20 Determinacion de los factores que afectan la regulacion y/o replicacion de genes.

Country Status (6)

Country Link
US (1) US6475719B1 (es)
EP (1) EP0469021B1 (es)
DE (1) DE69023642T2 (es)
ES (1) ES2081981T3 (es)
FI (1) FI88309C (es)
WO (1) WO1990012887A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2132306C (en) * 1992-03-16 2012-07-10 Jacob N. Wohlstadter Selection methods
FI95484C (fi) * 1994-01-17 1996-02-12 Marko Virta Menetelmä näytteessä olevan metallin määrittämiseksi
AU2946695A (en) * 1994-07-08 1996-02-09 Schering Corporation Method for identifying nucleic acids encoding c-fos promoter activating proteins
US5504093A (en) * 1994-08-01 1996-04-02 Otsuka Pharmaceutical Co., Ltd. Method for inhibiting nucleoside and nucleobase transport in mammalian cells, and method for inhibition of DNA virus replication
US5736331A (en) * 1995-07-08 1998-04-07 Schering Corporation Method for identifying nucleic acids encoding c-fos promoter activating proteins
US7132247B1 (en) 1998-09-17 2006-11-07 Regents Of The University Of Minnesota Composite devices incorporating biological material and methods
EP1141397A1 (en) * 1998-12-22 2001-10-10 Isis Innovation Limited Method of sequence identification
GB9910499D0 (en) * 1999-05-06 1999-07-07 Azur Env Ltd Assay reagent
EP1602720B1 (en) * 2003-03-05 2010-11-03 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Process for producing heterologous protein in e. coli
WO2004087069A2 (en) 2003-03-27 2004-10-14 Ptc Therapeutics, Inc. METHODS OF IDENTIFYING COMPOUNDS THAT TARGET tRNA SPLICING ENDONUCLEASE AND USES OF SAID COMPOUNDS AS ANTI-PROLIFERATIVE AGENTS
WO2004087884A2 (en) 2003-03-27 2004-10-14 Ptc Therapeutics, Inc TARGETING ENZYMES OF THE tRNA SPLICING PATHWAY FOR IDENTIFICATION OF ANTI-FUNGAL AND/OR ANTI-PROLIFERATIVE MOLECULES
WO2005014805A1 (en) 2003-08-08 2005-02-17 Regents Of The University Of Minnesota A structured material for the production of hydrogen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE424090B (sv) 1981-08-18 1982-06-28 Technion Res & Dev Foundation Forfarande for bestemning av en antibiotikakoncentration
US4806471A (en) * 1982-09-16 1989-02-21 A/S Alfred Benzon Plasmids with conditional uncontrolled replication behavior
GB8308236D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Dna vectors
EP0281104B1 (en) * 1987-03-03 1993-07-21 Research Association For Utilization Of Light Oil Novel plasmids

Also Published As

Publication number Publication date
WO1990012887A1 (en) 1990-11-01
FI88309B (fi) 1993-01-15
EP0469021B1 (en) 1995-11-15
DE69023642T2 (de) 1996-10-17
FI891899A7 (fi) 1990-10-21
DE69023642D1 (de) 1995-12-21
EP0469021A1 (en) 1992-02-05
FI891899A0 (fi) 1989-04-20
FI88309C (fi) 1993-04-26
US6475719B1 (en) 2002-11-05

Similar Documents

Publication Publication Date Title
ES2081981T3 (es) Determinacion de los factores que afectan la regulacion y/o replicacion de genes.
Klausner et al. Cis-trans models for post-transcriptional gene regulation
Bonnal et al. Heterogeneous nuclear ribonucleoprotein A1 is a novel internal ribosome entry site trans-acting factor that modulates alternative initiation of translation of the fibroblast growth factor 2 mRNA
Gruffat et al. The enhancer factor R of Epstein-Barr virus (EBV) is a sequence-specific DNA binding protein
UA42715C2 (uk) Полінуклеотидна вакцина на основі плазмідної днк, імуногенна композиція(варіанти)
ES8302774A1 (es) Un metodo para producir un vector de clonacion mejorado.
ES8607026A1 (es) Procedimiento para producir vectores hibridos de levadura
EP0653940A4 (en) GLIALMITOGENIC FACTORS, THEIR PRODUCTION AND USE.
DK1724354T3 (da) Cirkulær DNA-molekyle med en afhængig replikationsoprindelse, fremgangsmåde til fremstilling heraf og anvendelse heraf i genterapi
EP0219106A3 (en) Polypeptides that elicit antibodies against aids virus
DE3878627D1 (de) Zusammensetzung zur oberflaechenbehandlung von kautschuk.
DE60329366D1 (de) Induktierbare transposition beim transgenen organismus mit transposon-vektor
FI891848A0 (fi) Framstaellning av isolerade proteinhaltiga material med anvaendning av rekombinantkoppvirusvektorer fraon faoglar.
NO882854L (no) Korreksjon med dobbeltraadet rna av avvikende metabolske spor forbundet med ukontrollerte vekstsykluser for tumorceller og virus.
Duvoisin et al. A plasmid expression vector that permits stabilization of both mRNAs and proteins encoded by the cloned genes
ES2101537T3 (es) Expresion de oncogenes derivados de ntrk1 en celulas de feocromocitoma pc12 y uso de los mismos para el rastreo de compuestos anti-tirosina quinasa.
ES8405842A1 (es) Procedimiento de producir razas estables de celulas de mamiferos
Taniguchi et al. Decrease in the level of poly (ADP-ribose) synthetase during nerve growth factor-promoted neurite outgrowth in rat pheochromocytoma PC12 cells
Jamieson New genotypes in cod at Greenland
ATE92961T1 (de) Dns-sequenz.
NO912685L (no) Nye radikale litiumftalocyaninkrystaller, deres fremstillingsprosess og deres bruk til in vivo bestemmelse av molekylaert oksygen.
AU503128B2 (en) Method of butt joinig two sheets
Emili et al. A novel yeast protein influencing the response of RNA polymerase II to transcriptional activators
DE60034874D1 (de) Interne ribosom eintrittstelle (ires), vektor der diesen enthaltet und dessen therapeutische verwendung
Holbrook et al. Transcriptional activity of the gibbon ape leukemia virus in the interleukin 2 gene of MLA 144 cells

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 469021

Country of ref document: ES